The present invention discloses a device and a method for capillary chemiluminescence detection. The device comprises a liquid adding device, wherein the liquid adding device comprises: a bottom end of a funnel cup connected to a top end of the capillary body; a mounting bracket with one or more grooves; a liquid reagent cup disposed in each of the one or more grooves, a reagent set in the cup body, and a sealing film disposed at the opening of the cup body, a bottom end of each of the one or more grooves is connected to a top end of the funnel cup; a puncture device disposed in an inner bottom end of each of the one or more grooves. The present invention has the advantages of reducing the cost of the instrument, improving the reliability of the operation and so on.

The present disclosure provides variant major histocompatibility complex class II (MHCII) beta chains, as well as heterodimers and multimers including MHCII alpha chains and the variant MHCII beta chains. Also provided by the present disclosure are nucleic acids, expression cassettes, and expression vectors encoding the MHCII beta chains. The heterodimers and multimers of the present disclosure have a higher affinity for CD4 co-receptors than comparable reagents including wild type MHCII beta chains, and therefore are advantageous for use in methods of phenotyping or activating CD4.sup.+ T cells.

Disclosed is a method for obtaining information of a test substance, the method including: forming a complex by causing a capture substance to bind to a test substance in a specimen; selectively collecting at least the complex from the specimen; immobilizing the complex collected from the specimen, onto a base plate; and obtaining information regarding a structure of the test substance from the complex immobilized on the base plate.

Disclosed herein are methods, kits, tests, and systems for detecting, predicting, monitoring, or ruling out preeclampsia in pregnant women. Also provided herein are novel diagnostic markers, methods of data analysis, assay formats, and kits employing such markers to improve one or more characteristics of a test for identifying or ruling out preeclampsia based on biomarkers from patient samples.

The present invention relates to methods for detecting an analyte present in a fluid sample using a microfluidic device comprising a detection zone characterized by an optically transmissible portion and reagent(s) associated with a porous matrix, wherein the analyte is detected with an optical detector. The present invention also provides a microfluidic channel and a microfluidic cartridge for use in such a method.

A two-sided flow-through immunoassay testing device is provided. The device comprises a well having therein a plurality of orifices, the plurality of orifices serving to channel biologic material deposited into the well onto different immunoassay pods, wherein the immunoassay pods may contain immunoassay test layers stacked to create an immunoassay test. The device further includes a results window. Inside the device, and between the window and the pods, there are open sections below each pod to allow a user to view the results of the tests as presented on the reaction layers of the pods through the window.

A method for the preparation of one or more microfluidic chemotactic device prototypes wherein channel and/or barrier dimensions and chemo-attractant and/or cell binding agent concentration and/or type are varied for developing an optimized microfluidic chemotaxis device for a particular cell type and chemo- attractant type as well as instructions for use of same. This process may also require determination of cell density and cell solution volume.

The present invention generally relates to the collection, storage, and stabilization of biological samples (e.g., bodily fluids, such as whole blood, blood serum, and blood plasma), and analytes thereof. More particularly, the present invention relates to polymer-based biological sample collection devices, and methods of making and using the same.

An example system includes an input channel to receive particles through a first end, a separation chamber, at least two output channels, an integrated pump to facilitate flow through the separation chamber and a cell analysis portion. The separation chamber is in fluid communication with a second end of the input channel. The separation chamber has a passive separation structure including an array of columns spaced apart to facilitate separation of particles into at least two flow paths based on a size of the particles. The size associated with a first flow path of the at least two flow paths corresponds to a cell. A first output channel is to receive the first flow path corresponding to a cell. The cell analysis portion is coupled to the first output channel and is to perform at least one analysis associated with cells in the first output channel.

The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing and analyte characterization from one or more cells. Such polynucleotide processing may be useful for a variety of applications, including generation of labeled macromolecules, including major mistocompatability complex (MHC) molecules, dextramers, etc. Labeled macromolecules may be generated using an in vitro transcription reaction. Labeled macromolecules may be generated in one or more partitions.